Skip to main content
CRVS logo

CRVS · Corvus Pharmaceuticals, Inc. · Exempt Offerings

Track CRVS — free
$10.46 -0.08 (-0.76%) Q2 2026 earnings call transcript
Market Cap
$886.63M
Shares
84.12M
Volume · Oct 28 390.55K Avg daily vol (3M) 996.23K

Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.

No Exempt Offerings

No Form D exempt-offering notices are available for this stock yet.

Key facts CIK 1626971 CUSIP 221015100 13F (30d) 21 filings 21 filers Visit website Investor relations